Bone health in haemophilia carriers and persons with von Willebrand disease: A large database analysis

被引:6
作者
Citla-Sridhar, Divyaswathi [1 ]
Sidonio, Robert F., Jr. [2 ]
Ahuja, Sanjay P. [3 ,4 ]
机构
[1] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[2] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[3] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Cleveland, OH 44106 USA
关键词
bone health; fractures; haemophilia carriers; osteoarthritis; osteoporosis; risk factors; von Willebrand disease; MINERAL DENSITY; RISK-FACTORS; PREVALENCE; OSTEOPOROSIS; CHILDREN; PATIENT; DEATH; MALES;
D O I
10.1111/hae.14565
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Persons with haemophilia(PWH) have been shown to have low bone mineral density likely the result of prolonged immobility, recurrent hemarthrosis, decreased weight bearing, lower physical activity level and obesity. Bone health has been poorly characterized in haemophilia carriers (HC) and persons with von Willebrand disease (PWvWD). Aim: To estimate the prevalence of osteoporosis, osteoarthritis and bone fractures in HC and PWvWD and identify risk factors for poor bone health. Methods: This is a retrospective study using a population level, commercial database - Explorys (IBM Watson Health, Cleveland, USA). We compared prevalence rates of osteoporosis, osteoarthritis and fractures among cases (HC or PWvWD) and controls (general population without an underlying bleeding disorder) from 1999 to 2020. Prevalence of common risk factors for poor bone health were compared among cases and controls. Results: Among 72,917,850 active persons in the database, we identified 940 women with the diagnosis of HC and 19,580 PWvWD. Among HC and PWvWD, prevalence of osteoporosis, osteoarthritis and fractures were significantly higher in cases, when compared to controls. In HC, the prevalence of vitamin D deficiency, obesity, hypothyroidism, smoking, diabetes mellitus, hypocalcaemia, corticosteroid use, malignancy, renal failure and Nonsteroidal anti-inflammatory drugs (NSAID) use were significantly higher among the cases. In PWvWD, the prevalence of risk factors was significantly higher in cases when compared to controls. Conclusion: The prevalence of osteoporosis, osteoarthritis and fractures is significantly higher among HC and PWvWD. This data highlights the importance of screening patients for risk factors for poor bone health and provide education to prevent these complications.
引用
收藏
页码:671 / 678
页数:8
相关论文
共 43 条
  • [1] Choosing and using non-steroidal anti-inflammatory drugs in haemophilia
    Arachchillage, D. R. J.
    Makris, M.
    [J]. HAEMOPHILIA, 2016, 22 (02) : 179 - 187
  • [2] Increased Risk of Adverse Bone Health Outcomes in People with Bleeding Disorders
    Booth, Jason
    Lu, Mei
    Gallo, Daniel
    Ito, Diane
    Valentino, Leonard A.
    [J]. BLOOD, 2016, 128 (22)
  • [3] It is time for everyone to own the bone
    Bunta, Andrew D.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S477 - S482
  • [4] The ageing patient with haemophilia
    Canaro, Mariana
    Goranova-Marinova, Veselina
    Berntorp, Erik
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 : 17 - 22
  • [5] Bone Status of Children With Hemophilia A Assessed With Quantitative Ultrasound Sonography (QUS) and Dual Energy X-ray Absorptiometry (DXA)
    Christoforidis, Athanasios
    Economou, Marina
    Papadopoulou, Eleni
    Kazantzidou, Eirini
    Gompakis, Nikolaos
    Athanassiou-Metaxa, Miranda
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2010, 32 (07) : E259 - E263
  • [6] Citla Sridhar D., 2019, BLOOD, P3448
  • [7] Glucocorticoid-induced osteoporosis: an update
    Compston, Juliet
    [J]. ENDOCRINE, 2018, 61 (01) : 7 - 16
  • [8] Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV
    Darby, Sarah C.
    Kan, Sau Wan
    Spooner, Rosemary J.
    Giangrande, Paul L. F.
    Hill, Frank G. H.
    Hay, Charles R. M.
    Lee, Christine A.
    Ludlam, Christopher A.
    Williams, Michael
    [J]. BLOOD, 2007, 110 (03) : 815 - 825
  • [9] Severity of osteoporosis: what is the impact of co-morbidities?
    David, Claire
    Confavreux, Cyrille B.
    Mehsen, Nadia
    Paccou, Julien
    Leboime, Ariane
    Legrand, Erick
    [J]. JOINT BONE SPINE, 2010, 77 : S103 - S106
  • [10] Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)
    Dennison, Elaine M.
    Compston, Juliet E.
    Flahive, Julie
    Siris, Ethel S.
    Gehlbach, Stephen H.
    Adachi, Jonathan D.
    Boonen, Steven
    Chapurlat, Roland
    Diez-Perez, Adolfo
    Anderson, Frederick A., Jr.
    Hooven, Frederick H.
    LaCroix, Andrea Z.
    Lindsay, Robert
    Netelenbos, J. Coen
    Pfeilschifter, Johannes
    Rossini, Maurizio
    Roux, Christian
    Saag, Kenneth G.
    Sambrook, Philip
    Silverman, Stuart
    Watts, Nelson B.
    Greenspan, Susan L.
    Premaor, Melissa
    Cooper, Cyrus
    [J]. BONE, 2012, 50 (06) : 1288 - 1293